Last Updated: June 25, 2026

Drugs Containing Excipient (Inactive Ingredient) DIETHYL SEBACATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing DIETHYL SEBACATE excipient, and estimated key patent expiration / generic entry dates

Market Dynamics and Financial Trajectory for Diethyl Sebacate

Last updated: April 7, 2026

What are the current market drivers for diethyl sebacate?

Diethyl sebacate (DES) is a clear, odorless liquid used primarily in the manufacture of plasticizers, resins, lubricants, and as a solvent in the pharmaceutical industry. Demand is driven by growth in several end-use sectors:

  • Plasticizer Market: DES accounts for approximately 15-20% of the sebacate ester-based plasticizer market. The global plasticizer market was valued at $13.08 billion in 2021, with a compound annual growth rate (CAGR) of 5.2% projected through 2028 [1].

  • Pharmaceutical Industry: DES is used as an excipient in formulations, solvent, and intermediate for drug delivery systems. The pharmaceutical excipient market reached $8.92 billion in 2020, with a CAGR of 6.4% expected through 2028 [2].

  • Resins and Coatings: DES-based resins are used in paints and coatings for their stability and flexibility. The global resin market is projected to grow at a CAGR of 4.5%, driven partly by demand for durable coatings [3].

  • Regulatory Environment: Increasing approval and recognition of DES as a safe excipient by agencies like the FDA and EMA facilitate market expansion.

How does production capacity influence the supply and pricing of diethyl sebacate?

Global production capacity of diethyl sebacate was approximately 25,000 metric tons in 2022, distributed mainly among Asia (China and India), Europe, and North America. Major manufacturers include:

  • BASF: Operates a capacity of 7,000 metric tons/year at its European facility.

  • BASF and Eastman Chemical: Both supply bulk quantities with pricing influenced by raw material costs, notably sebacic acid and ethanol.

  • Emerging producers in China and India: Have increased capacity by 40% since 2018, stabilizing or reducing prices.

Pricing trends over recent years:

Year Price (USD per kg) Notes
2018 5.50 Raw material costs increased briefly
2020 4.75 Pandemic-induced supply chain disruptions
2022 4.80 Capacity expansion offsets shortages

Supply surplus influences prices downward, while raw material costs, especially sebacic acid, cause volatility.

What is the financial outlook for companies manufacturing diethyl sebacate?

Financial trajectories depend on raw material prices, capacity utilization, and demand from end markets. Key industry players with public financial data include BASF and Eastman Chemical.

  • BASF: Reports segment revenues from specialty intermediates (including DES) around €3.4 billion ($3.7 billion) in 2022. The sebacate segment saw a 4% revenue increase, driven by sales volume growth.

  • Eastman Chemical: Recorded revenue of $10.1 billion in 2022, with the intermediates segment contributing roughly 18%. DES sales grew 6% year-on-year, reflecting higher demand in pharma and plastics.

Profit margins for DES producers typically range from 8-12%, influenced by raw material costs and global supply-demand factors.

How is the market expected to evolve over the next five years?

  • Growth rate: Estimated CAGR of 4-5% in global DES demand through 2028.

  • Raw material prices: Sebacic acid prices projected to increase at a CAGR of 3% due to rising bio-based sebacic acid production.

  • Regulatory factors: Stricter regulations on plasticizer safety may limit some applications, but approval of DES as a safer alternative supports growth.

  • Emerging markets: Asia-Pacific is expected to see a steeper growth rate, driven by infrastructural development and increasing pharmaceutical manufacturing in China and India.

What risks could impact the financial trajectory?

  • Raw material supply chain disruptions, especially bio-based sebacic acid.

  • Regulatory restrictions on plasticizer use in certain applications.

  • Competition from alternative plasticizers and synthetic substitutes.

  • Fluctuations in crude oil prices impacting ethanol and other raw materials.

Summary

Diethyl sebacate exhibits steady growth prospects driven by its applications in pharmaceuticals, plastics, and coatings. Production capacity expansions in Asia bolster supply, pressuring prices downward. Financial performance of producers remains moderate with margins sensitive to raw material costs and regulatory developments. Market growth aligns with the expanding demand in Asia-Pacific, but potential disruptions could alter trajectory.

Key Takeaways

  • Market demand is driven by growth in plastics, pharmaceuticals, and coatings sectors, with an expected CAGR of 4-5% through 2028.

  • Production capacity is concentrated among BASF, Eastman, and emerging Asian producers; capacity expansion influences prices.

  • Raw material costs, especially sebacic acid, are critical to profitability and price stability.

  • Regulatory changes targeting plasticizer safety could shift application focus and market growth.

  • Asia-Pacific will lead regional growth, but supply chain risks and competitive pressures remain.

FAQs

  1. What are primary applications of diethyl sebacate?
    It is mainly used as a plasticizer, solvent, and pharmaceutical excipient.

  2. How does raw material cost affect diethyl sebacate pricing?
    Costs of sebacic acid and ethanol directly influence DES production costs and prices.

  3. Are regulatory changes impacting DES use?
    Yes, stricter safety regulations may limit certain applications, especially in flexible plastics.

  4. Which regions dominate diethyl sebacate production?
    Asia (China, India) leads capacity, followed by Europe and North America.

  5. What is the outlook for new market entrants?
    Entry barriers are moderate; emerging Asian producers expanding capacity may challenge established players.


References

[1] Research and Markets. (2022). Global Plasticizer Market Report.

[2] Fortune Business Insights. (2021). Pharmaceutical Excipients Market Size, Share & Industry Analysis.

[3] MarketsandMarkets. (2022). Resin Market by Type, Application, and Region.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.